Article · 26 Sep 2025
PerspectivePublished 2016
Variable Market Exclusivity Periods for Pharmaceuticals
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmaceutical companies are given a market exclusivity period that does not vary based on the level of research and development (R&D) or the profits earned. The main purpose of this period is to protect the intellectual capital invested in a product allowing the inventor sufficient time to recoup the R&D costs and to be able to earn a profit. Currently, only 2 in 10 marketed drugs are profitable and drug companies earn substantial profits on only a few blockbuster drugs. As a result, there are many neglected diseases and drug companies charge very high prices for these few profitable drugs. These high prices can restrict access; for example, less than 10% of people with hepatitis C receive the appropriate drug primarily because of its high cost. A variable length market exclusivity period that takes into account a drug’s R&D cost (including the cost of all related products) and profits would provide greater incentives to invest in total R&D, R&D for a wider range of diseases and result in lower prices for expensive specialty drugs leading to greater access.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Health Economics & Outcome Research: Open Access.
Article · 26 Sep 2025
Breaking down the fda approval process what every pharma innovator should know
Article · 26 Sep 2025
Inside a licensing agreement key clauses that shape pharma partnerships
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Economics & Outcome Research: Open Access
- SubjectBusiness & Management
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Michael Hsu”
- BylineArticles whose byline prints “Ali Thaver”
- BylineArticles whose byline prints “Gerard Anderson”

